AbbVie Earnings, Income Beat in Q2 By Investing.com

0

© Reuters. AbbVie earnings and sales exceeded second quarter

Investing.com – AbbVie (NYSE 🙂 reported the second quarter on Friday, which beat analysts’ forecasts and sales were above expectations.

AbbVie announced earnings per share of $ 3.11 on sales of $ 13.96 billion. Analysts polled by Investing.com expected earnings per share of $ 3.08 on sales of $ 13.63 billion.

AbbVie stocks are up 10% year-to-date, still 0.20% from their 52-week high of $ 119.11 on July 29. They are behind the S&P 500, which is up 17.65% year-to-date.

AbbVie shares lost 1.24% in pre-market trading after the report.

AbbVie follows other major healthcare gains this month

AbbVie’s report follows HCA’s bottom line on July 20, which posted earnings per share of $ 4.37 on sales of $ 14.44 billion.

Centene had exceeded expectations on Tuesday with earnings per share of $ 1.25 on sales of $ 31.03 billion, compared with a forecast of $ 1.22 on sales of 30.19 billion U.S. dollar.

Stay up to date on all upcoming earnings reports by visiting Investing.com’s Earnings Calendar

Disclaimer: Fusion Media would like to remind you that the data contained on this website is not necessarily real time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.

Fusion Media or any other person involved in Fusion Media assumes no liability for any loss or damage that might arise from reliance on the information contained on this website, including data, prices, charts and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment.

Leave A Reply

Your email address will not be published.